Parkinson's Disease Tulip


advertisement
 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 03-14-2013, 08:38 AM #1
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,531
15 yr Member
Default OT - What’s to be done to reduce the high turnover rate for clinical trial investigat

http://medcitynews.com/2013/03/whats...investigators/
Quote:
The fundamental problem, said Kenneth Getz, the director of sponsored programs for the Tufts Center, is the needlessly complicated design of clinical trials shaped by complex regulatory requirements from the U.S. Food and Drug Administration. Protocol design is an area the center has focused on for the past 10 years, according to Getz.


Read more: http://medcitynews.com/2013/03/whats...#ixzz2NWNBg7g3

Last edited by Chemar; 03-14-2013 at 06:12 PM. Reason: Copyright 2013 MedCity News. All Rights Reserved.
soccertese is offline   Reply With QuoteReply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
CLINICAL TRIAL...Phase III Trial with Pimavanserin in Patients with PD Psychosis Stitcher Parkinson's Disease Clinical Trials 0 06-16-2007 12:23 AM


All times are GMT -5. The time now is 12:49 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.